Cargando…
Biological Activity of Coumarin Derivatives as Anti-Leishmanial Agents
Cutaneous leishmaniasis affects nearly 0.7 to 1.3 million people annually. Treatment of this disease is difficult due to lack of appropriate medication and the growing problem of drug resistance. Natural compounds such as coumarins serve as complementary therapeutic agents in addition to the current...
Autores principales: | Mandlik, Vineetha, Patil, Sohan, Bopanna, Ramanamurthy, Basu, Sudipta, Singh, Shailza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5074534/ https://www.ncbi.nlm.nih.gov/pubmed/27768694 http://dx.doi.org/10.1371/journal.pone.0164585 |
Ejemplares similares
-
Molecular docking and molecular dynamics simulation study of inositol phosphorylceramide synthase – inhibitor complex in leishmaniasis: Insight into the structure based drug design
por: Mandlik, Vineetha, et al.
Publicado: (2016) -
Systems biology of autophagy in leishmanial infection and its diverse role in precision medicine
por: Guhe, Vrushali, et al.
Publicado: (2023) -
Molecular evolution of the enzymes involved in the sphingolipid metabolism of Leishmania: selection pressure in relation to functional divergence and conservation
por: Mandlik, Vineetha, et al.
Publicado: (2014) -
LmSmdB: an integrated database for metabolic and gene regulatory network in Leishmania major and Schistosoma mansoni
por: Patel, Priyanka, et al.
Publicado: (2015) -
β-Nitrostyrenes as Potential Anti-leishmanial Agents
por: Shafi, Syed, et al.
Publicado: (2016)